Latest round

Seed

Last raised

Oct 2020

Total raised

$4.5M

Investors

4

About Lassogen

Lassogen, Inc.Founded in 2019 and headquartered in San Diego, US, Lassogen, Inc. specializes in creating novel therapeutic agents called Lassotides™ derived from unique lasso peptides.Lassogen, Inc. focuses on developing and optimizing Lassotides™, which are engineered lasso peptides that function as 3D scaffolds, combining advantages of traditional antibodies and small molecules to treat diseases that remain inadequately addressed. The primary users of these therapies are healthcare providers, researchers, and patients seeking improved treatment options.Lassogen, Inc. generates revenue through strategic partnerships with pharmaceutical firms and research institutions, focusing on the commercialization of Lassotides™. These partnerships often involve collaborative agreements for research and development, leading to potential co-development or licensing deals. The company is actively looking to penetrate new markets in Europe and Asia by 2023, aiming to broaden the accessibility of its innovative therapies.

Who invested in Lassogen

4 investors across 1 round

See all investors in Lassogen

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Oct 13, 2020

    Amount

    $4.5M

    Investors

    Locked

Questions about Lassogen

Who invested in Lassogen?

Lassogen has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Lassogen raised?

Lassogen has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Lassogen last raise money?

Lassogen's most recent round on record is a Seed, in Oct 2020.

What does Lassogen do?

Lassogen is a biotechnology company.

Where is Lassogen headquartered?

Lassogen is headquartered in San Diego, US.

Which VCs invest in companies like Lassogen?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lassogen's stage. Their profiles are linked below.

Raising like Lassogen? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.